Dihydroergotamine and Lenvatinib Mesylate
Determining the interaction of Dihydroergotamine and Lenvatinib Mesylate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dihydroergotamine
Brand name: DHE. 45, Migranal
Synonyms: Dihydroergotamine (injection)
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvatinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dihydroergotamine-Lenvima
- Dihydroergotamine-Lenvima (14 MG Daily Dose)
- Dihydroergotamine-Lenvima (18 MG Daily Dose)
- Dihydroergotamine-Lenvima (20 MG Daily Dose)
- Dihydroergotamine-Lenvima (24 MG Daily Dose)
- Dihydroergotamine-Lenvima (8 MG Daily Dose)
- Lenvatinib Mesylate-Dihydroergotamine injection
- Lenvatinib Mesylate-Dihydroergotamine Mesylate
- Lenvatinib Mesylate-Dihydroergotamine nasal
- Lenvatinib Mesylate-Dihydroergotamine Nasal Spray
- Lenvatinib Mesylate-Dilacor XR
- Lenvatinib Mesylate-Dilantin